 | Up a level |
Moulin, Philippe, Dufour, Robert, Averna, Maurizio 
ORCID: 0000-0003-3558-9209, Arca, Marcello, Cefalu, Angelo B., Noto, Davide, D'Erasmo, Laura ORCID: 0000-0002-9174-4667, Di Costanzo, Alessia, Marcais, Christophe, Alvarez-Sala Walther, Luis Antonio, Banach, Maciej ORCID: 0000-0001-6690-6874, Boren, Jan, Cramb, Robert, Gouni-Berthold, Ioanna, Hughes, Elizabeth, Johnson, Colin, Pinto, Xavier, Reiner, Zeljko, van Lennep, Jeanine Roeters, Soran, Handrean, Stefanutti, Claudia ORCID: 0000-0003-3448-2426, Stroes, Erik and Bruckert, Eric
(2018).
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score.
Data Brief, 21.
S. 1334 - 1337.
AMSTERDAM:
ELSEVIER SCIENCE BV.
ISSN 2352-3409
Moulin, Philippe, Dufour, Robert, Averna, Maurizio ORCID: 0000-0003-3558-9209, Arca, Marcello, Cefalu, Angelo B., Noto, Davide, D'Erasmo, Laura ORCID: 0000-0002-9174-4667, Di Costanzo, Alessia, Marcais, Christophe, Alvarez-Sala Walther, Luis Antonio, Banach, Maciej ORCID: 0000-0001-6690-6874, Boren, Jan, Cramb, Robert, Gouni-Berthold, Ioanna, Hughes, Elizabeth, Johnson, Colin, Pinto, Xavier, Reiner, Zeljko, van Lennep, Jeanine Roeters, Soran, Handrean, Stefanutti, Claudia ORCID: 0000-0003-3448-2426, Stroes, Erik and Bruckert, Eric
(2018).
Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an FCS score.
Atherosclerosis, 275.
S. 265 - 273.
CLARE:
ELSEVIER IRELAND LTD.
ISSN 1879-1484
Raal, Frederick J., Stein, Evan A., Dufour, Robert, Turner, Traci, Civeira, Fernando, Burgess, Lesley, Langslet, Gisle, Scott, Russell ORCID: 0000-0002-2107-6480, Olsson, Anders G., Sullivan, David, Hovingh, G. Kees, Cariou, Bertrand ORCID: 0000-0002-1580-8040, Gouni-Berthold, Ioanna, Somaratne, Ransi, Bridges, Ian, Scott, Rob, Wasserman, Scott M. and Gaudet, Daniel
(2015).
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial.
Lancet, 385 (9965).
S. 331 - 341.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X